Immupharma Share News (IMM)

ImmuPharma's Lupuzor trial on track for 2017 completion

(ShareCast News) - ImmuPharma has reached a number of important milestones in the phase three clinical trial of Lupuzor. The AIM listed company provided an update to the market on Wednesday about the drug trial, its lead programme for the potential breakthrough compound for life threatening auto imm

WINNERS & LOSERS SUMMARY: Housebuilders And Estate Agents Torn Down

ImmuPharma Says Lupuzor Trials Set To Start In US This Year

ImmuPharma Appoints Non-Executive Chairman As Loss Narrows

ImmuPharma Says Chairman And Co-Founder Richard Warr Dies

ImmuPharma Secures Financing To Continue Lupuzor Progress (ALLISS)

LONDON MORNING BRIEFING: AB Foods Lifted To Buy From Sell By Goldman

AGM, EGM Calendar - Week Ahead

AGM, EGM Calendar - Week Ahead

ImmuPharma Chairman Takes Leave To Deal With Health Issue

Immupharma To Focus On Lupuzor, 2014 Loss Narrows On Trial End

Immupharma Says Cancer Therapy Trial Meets Primary Objective

UK MIDDAY BRIEFING: Royal Mail Up As It Meets Low Expectations

UK WINNERS & LOSERS: Oxford Instruments Falls On Another Warning

ImmuPharma Shares Up 22% On Simbec-Orion Lupuzor Agreement